ACE inhibitors and AT1 antagonists lower blood pressure and improve albuminuria in this model, yet without preventing glomerulosclerosis (Mifsud et al., 2002; Roksnoer et al., 2016; Uijl et al., 2020). Here, AGTR1 is linked to glomerulosclerosis.